|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
|
WO1986005519A1
(en)
|
1985-03-15 |
1986-09-25 |
James Summerton |
Polynucleotide assay reagent and method
|
|
US5521063A
(en)
|
1985-03-15 |
1996-05-28 |
Antivirals Inc. |
Polynucleotide reagent containing chiral subunits and methods of use
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US5217866A
(en)
|
1985-03-15 |
1993-06-08 |
Anti-Gene Development Group |
Polynucleotide assay reagent and method
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
AU659482B2
(en)
|
1991-06-28 |
1995-05-18 |
Massachusetts Institute Of Technology |
Localized oligonucleotide therapy
|
|
WO1997022371A1
(en)
|
1995-12-18 |
1997-06-26 |
Collagen Corporation |
Crosslinked polymer compositions and methods for their use
|
|
US6245747B1
(en)
|
1996-03-12 |
2001-06-12 |
The Board Of Regents Of The University Of Nebraska |
Targeted site specific antisense oligodeoxynucleotide delivery method
|
|
US20060241075A1
(en)
|
2001-05-18 |
2006-10-26 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of desmoglein gene expression using short interfering nucleic acid (siNA)
|
|
US20040029129A1
(en)
|
2001-10-25 |
2004-02-12 |
Liangsu Wang |
Identification of essential genes in microorganisms
|
|
US6965025B2
(en)
|
2001-12-10 |
2005-11-15 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of connective tissue growth factor expression
|
|
CA2522184A1
(en)
|
2003-04-17 |
2004-11-04 |
The Trustees Of Columbia University In The City Of New York |
Desmoglein 4 is a novel gene involved in hair growth
|
|
US7468418B2
(en)
|
2003-04-29 |
2008-12-23 |
Avi Biopharma., Inc. |
Compositions for enhancing transport of molecules into cells
|
|
US20050288246A1
(en)
|
2004-05-24 |
2005-12-29 |
Iversen Patrick L |
Peptide conjugated, inosine-substituted antisense oligomer compound and method
|
|
EP2351839A3
(en)
*
|
2004-07-02 |
2011-10-05 |
AVI BioPharma, Inc. |
Antisense antibacterial method and compound
|
|
US20070154896A1
(en)
|
2005-02-11 |
2007-07-05 |
International Business Machines Corporation |
System and method for identification of MicroRNA target sites and corresponding targeting MicroRNA sequences
|
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
|
US7790694B2
(en)
|
2005-07-13 |
2010-09-07 |
Avi Biopharma Inc. |
Antisense antibacterial method and compound
|
|
WO2007009094A2
(en)
*
|
2005-07-13 |
2007-01-18 |
Avi Biopharma, Inc. |
Antisense antibacterial method and compound
|
|
WO2007025016A1
(en)
|
2005-08-25 |
2007-03-01 |
Texas Tech University System |
Inhibition of metallo-beta-lactamase by double-stranded dna
|
|
WO2009005793A2
(en)
|
2007-06-29 |
2009-01-08 |
Avi Biopharma, Inc. |
Tissue specific peptide conjugates and methods
|
|
US20100016215A1
(en)
|
2007-06-29 |
2010-01-21 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
|
RU2606627C2
(ru)
|
2007-11-15 |
2017-01-10 |
Серепта Терапьютикс,Инк. |
Способ синтеза морфолиновых олигомеров
|
|
US8076476B2
(en)
|
2007-11-15 |
2011-12-13 |
Avi Biopharma, Inc. |
Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits
|
|
US8299206B2
(en)
|
2007-11-15 |
2012-10-30 |
Avi Biopharma, Inc. |
Method of synthesis of morpholino oligomers
|
|
US20110269665A1
(en)
|
2009-06-26 |
2011-11-03 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
|
US9914745B2
(en)
|
2009-08-14 |
2018-03-13 |
Indian Association For The Cultivation Of Science |
Morpholino-based antisense agent
|
|
US10017763B2
(en)
|
2010-09-03 |
2018-07-10 |
Sarepta Therapeutics, Inc. |
dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups
|
|
ES2607603T3
(es)
|
2010-09-30 |
2017-04-03 |
Nippon Shinyaku Co., Ltd. |
Derivado de ácido morfolino nucleico
|
|
AU2011326364B2
(en)
|
2010-11-12 |
2016-08-11 |
Sarepta Therapeutics, Inc. |
Antisense antibacterial compounds and methods
|
|
US20120213663A1
(en)
|
2011-02-23 |
2012-08-23 |
King Fahd University Of Petroleum And Minerals |
Method of removing e. coli bacteria from an aqueous solution
|
|
CA3092114A1
(en)
|
2011-05-05 |
2012-11-08 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
|
US9161948B2
(en)
|
2011-05-05 |
2015-10-20 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
|
KR101317263B1
(ko)
|
2011-07-05 |
2013-10-10 |
(주)지노첵 |
리얼타임 ｐｃｒ을 이용한 카바페넴 내성 장내균 검사 방법 및 키트
|
|
WO2013011072A1
(en)
|
2011-07-20 |
2013-01-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Carbapenemase and antibacterial treatment
|
|
CA2948373A1
(en)
|
2014-05-16 |
2015-11-19 |
Oregon State University |
Antisense antibacterial compounds and methods
|
|
CA2948568A1
(en)
|
2014-05-19 |
2015-11-26 |
David Greenberg |
Antisense antibacterial compounds and methods
|
|
EP3240794A4
(en)
|
2014-12-31 |
2018-10-31 |
Oregon State University |
Antisense antibacterial compounds and methods
|
|
US11142764B2
(en)
|
2015-12-23 |
2021-10-12 |
Board Of Regents, The University Of Texas System |
Antisense antibacterial compounds and methods
|
|
AU2016379399B2
(en)
|
2015-12-23 |
2022-12-08 |
Board Of Regents, The University Of Texas System |
Antisense antibacterial compounds and methods
|